Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001193125-25-282840·ALGER ASSOCIATES INC
Schedule 13G ownership disclosure
Forte Biosciences Inc
Common Stock · CUSIP: 34962G208
Event date: 2025-09-30
- Filing-level shares
- 1,634,267
- Percent of class
- 13.1%
- Alger Associates, Inc.
Shares: 1,634,267 · Class: 13.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-282840
- Form type
- SCHEDULE 13G/A
- Filer
- ALGER ASSOCIATES INC
- CIK
- CIK 1000264
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership